Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is there a ten-year valve?

B C Paton

    Advances in Cardiology
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Aortic homografts and certain mechanical valves show comparable long-term survival rates. Newer valve designs and improved patient care contribute to better outcomes in cardiac valve replacement surgery.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prosaposin deficiency -- a rarely diagnosed, rapidly progressing, neonatal neurovisceral lipid storage disease. Report of a further patient.

    Neuropediatrics·2005
    Same author

    "From Larrey to Mills": the road to rapid rewarming--a commentary.

    Wilderness & environmental medicine·2002
    Same author

    Molecular analysis of genomic DNA allows rapid, and accurate, prenatal diagnosis of peroxisomal D-bifunctional protein deficiency.

    Prenatal diagnosis·2002
    Same author

    Saposins (sap) A and C activate the degradation of galactosylsphingosine.

    FEBS letters·2001
    Same author

    An Australasian diagnostic service for the neuronal ceroid lipofuscinoses.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2001
    Same author

    Molecular changes in the D-bifunctional protein cDNA sequence in Australasian patients belonging to the bifunctional protein complementation group.

    Cell biochemistry and biophysics·2001
    Same journal

    Conclusion.

    Advances in cardiology·2012
    Same journal

    Challenges in atrial fibrillation.

    Advances in cardiology·2012
    Same journal

    Antiplatelet therapy in stroke prevention.

    Advances in cardiology·2012
    Same journal

    Bleeding and the use of antiplatelet agents in the management of acute coronary syndromes and atrial fibrillation.

    Advances in cardiology·2012
    Same journal

    Stents and antiplatelet therapy.

    Advances in cardiology·2012
    Same journal

    Genetic considerations.

    Advances in cardiology·2012
    See all related articles

    Area of Science:

    • Cardiovascular Surgery
    • Biomaterials Science
    • Medical Device Engineering

    Background:

    • The era of exclusive valve replacement began in 1960.
    • Aortic homografts have been continuously used since 1962.
    • Early mechanical valves like Smeloff-Cutter and Starr-Edwards series were developed.

    Purpose of the Study:

    • To evaluate the long-term survival rates of continuously used cardiac valves.
    • To compare the efficacy of different valve designs, including homografts and mechanical valves.
    • To identify factors contributing to improved surgical outcomes in valve replacement.

    Main Methods:

    • Retrospective analysis of survival data for various cardiac valve prostheses.
    • Comparison of 10-year survival rates for aortic homografts, Smeloff-Cutter, and Starr-Edwards valves.

    Related Experiment Videos

  • Assessment of survival trends for newer generations of homografts, tissue, and prosthetic valves.

    • Main Results:

    • Aortic homografts demonstrate a 10-year survival rate of 60-70%.
    • Smeloff-Cutter and Starr-Edwards valves show approximately 70% survival after 8 years, comparable to homografts.
    • More recent valve series (homografts, tissue, prosthetic) suggest improved 10-year survival compared to older designs.

    Conclusions:

    • Aortic homografts and select mechanical valves offer comparable long-term survival.
    • Advancements in patient selection, myocardial protection, and postoperative care significantly enhance surgical outcomes.
    • Continuous innovation in valve design and surgical techniques drives progressive improvements in cardiac valve replacement success rates.